QIAGEN, LLC - LIASON QUANTIFERON-TB GOLD PLUSE US & CONTROL QUANTIFERON-TB GOLD PLUS.

PIID: 36C24824P1262

Signed Date: Oct 1, 2025Effective Date: Apr 16, 2024End Date: Closes in 112 days

Award $

$102K

Vendor

QIAGEN, LLC

NAICS

325412

Signed Date

Oct 1, 2025

Key Details

Dollars Obligated

$101,595.89

Base & All Options

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6640 - LABORATORY EQUIPMENT AND SUPPLIES

Extent Competed

NOT COMPETED

Number of Offers

Place of Performance

RIVIERA BEACH, FL, 334106400, CD-FL-21

Description

LIASON QUANTIFERON-TB GOLD PLUSE US & CONTROL QUANTIFERON-TB GOLD PLUS.

Context & Analysis

On Oct 1, 2025, Department of Veterans Affairs obligated $101,595.89 to QIAGEN, LLC for liason quantiferon-tb gold pluse us & control quantiferon-tb gold plus.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in RIVIERA BEACH, FL. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.